tiprankstipranks
Trending News
More News >
Cautious Hold Rating on SAGE Therapeutics Amid Financial Pressures and Strategic Uncertainties
PremiumRatingsCautious Hold Rating on SAGE Therapeutics Amid Financial Pressures and Strategic Uncertainties
1M ago
Sage Therapeutics reports Q1 EPS ($1.01), consensus ($1.01)
Premium
The Fly
Sage Therapeutics reports Q1 EPS ($1.01), consensus ($1.01)
1M ago
Is SAGE a Buy, Before Earnings?
Premium
Pre-Earnings
Is SAGE a Buy, Before Earnings?
1M ago
Sage Therapeutics Chief Medical Officer to step down
PremiumThe FlySage Therapeutics Chief Medical Officer to step down
3M ago
SAGE Therapeutics: Hold Rating Amid Gradual Growth Prospects and Market Challenges
Premium
Ratings
SAGE Therapeutics: Hold Rating Amid Gradual Growth Prospects and Market Challenges
3M ago
Sage Therapeutics price target established at JPMorgan
Premium
The Fly
Sage Therapeutics price target established at JPMorgan
3M ago
Sage Therapeutics price target lowered to $7 from $9 at Baird
PremiumThe FlySage Therapeutics price target lowered to $7 from $9 at Baird
4M ago
Cautious Outlook on SAGE Therapeutics Amid Strategic Uncertainty and Pipeline Ambiguities
Premium
Ratings
Cautious Outlook on SAGE Therapeutics Amid Strategic Uncertainty and Pipeline Ambiguities
4M ago
Sage Therapeutics price target lowered to $8 from $9 at Canaccord
Premium
The Fly
Sage Therapeutics price target lowered to $8 from $9 at Canaccord
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100